Allergan Inc. issued textured breast implant recall because of its linkage with rare cancer. Rare lymphoma cases in disproportionate amount were observed by the company resulting into textured breast implant recall.
Women who have implants and are not facing any concerns are not recommended to remove them, as per the USFDA.
The textured surface was developed to safeguard slippage issue. It is only accountable for 5% models available in the U.S. market.
Mr Vinod Arora, Principal Advisor, IGMPI
Placement testimonials: Our alumni are working with Fortune 500 and global Pharmaceutical, Food and healthcare giants like